Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
12,214,064
-
Share change
-
+749,924
-
Total reported value
-
$427,112,324
-
Put/Call ratio
-
53%
-
Price per share
-
$34.97
-
Number of holders
-
93
-
Value change
-
+$36,655,592
-
Number of buys
-
60
-
Number of sells
-
28
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q2 2018
As of 30 Jun 2018,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,214,064 shares.
The largest 10 holders included
CPMG Inc, BlackRock Inc., VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), EMERALD ADVISERS INC/PA, EMERALD MUTUAL FUND ADVISERS TRUST, FMR LLC, Cormorant Asset Management, LP, AMERIPRISE FINANCIAL INC, and BOXER CAPITAL, LLC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.